NMR and mass spectrometry studies of putative interactions of cell cycle proteins pRb and CDK6 with cell differentiation proteins MyoD and ID-2

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1750, Issue 1, 2005, Pages 48-60

  Smialowski, Pawel ^a   Singh, Mahavir ^a   Mikolajka, Aleksandra ^a   Majumdar, Sudipta ^a   Joy, Joma K ^a   Nalabothula, Narasimharao ^a   Krajewski, Marcin ^a   Degenkolbe, Roland ^b   Bernard, Hans Ulrich ^b   Holak, Tad A ^a  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

CDK6; Complex; Id 2; Interaction; MyoD; Retinoblastoma protein

Indexed keywords

AMINO ACID; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE 6; DNA; HELIX LOOP HELIX PROTEIN; INHIBITOR OF DIFFERENTIATION 2; MYOD PROTEIN; PROTEIN E7; PROTEIN P19; RETINOBLASTOMA PROTEIN; VIRUS LARGE T ANTIGEN;

AFFINITY CHROMATOGRAPHY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; GEL FILTRATION CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIMIAN VIRUS 40; WART VIRUS;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CHICKENS; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASES; DNA; DNA-BINDING PROTEINS; HELIX-LOOP-HELIX MOTIFS; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MYOD PROTEIN; ONCOGENE PROTEINS, VIRAL; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS;

EID: 20444393161     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2005.03.012     Document Type: Article

References (54)

1. K. Walsh, and H. Perlman Cell cycle exit upon myogenic differentiation Curr. Opin. Genet. Dev. 7 1997 597 602
2. T. Sandal Molecular aspects of the mammalian cell cycle and cancer Oncologist 7 2002 73 81
3. J.D. Norton ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis J. Cell Sci. 113 Pt. 22 2000 3897 3905
4. A.B. Lassar, R.L. Davis, W.E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, and H. Weintraub Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo Cell 66 1991 305 315
5. M.E. Massari, and C. Murre Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms Mol. Cell. Biol. 20 2000 429 440
6. H. Weintraub, R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T.K. Blackwell, D. Turner, R. Rupp, and S. Hollenberg The myoD gene family: nodal point during specification of the muscle cell lineage Science 251 1991 761 766
7. M. Crescenzi, T.P. Fleming, A.B. Lassar, H. Weintraub, and S.A. Aaronson MyoD induces growth arrest independent of differentiation in normal and transformed cells Proc. Natl. Acad Sci. U. S. A. 87 1990 8442 8446
8. W. Gu, J.W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation Cell 72 1993 309 324
9. C.S. Guo, C. Degnin, T.A. Fiddler, D. Stauffer, and M.J. Thayer Regulation of MyoD activity and muscle cell differentiation by MDM2, pRb, and Sp1 J. Biol. Chem. 278 2003 22615 22622
10. P.L. Puri, S. Iezzi, P. Stiegler, T.T. Chen, R.L. Schiltz, G.E. Muscat, A. Giordano, L. Kedes, J.Y. Wang, and V. Sartorelli Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis Mol. Cell 8 2001 885 897
11. J.M. Zhang, Q. Wei, X. Zhao, and B.M. Paterson Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4 EMBO J. 18 1999 926 933
12. J.M. Zhang, X. Zhao, Q. Wei, and B.M. Paterson Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation EMBO J. 18 1999 6983 6993
13. A. Pagliuca, P.C. Bartoli, S. Saccone, G. Della Valle, and L. Lania Molecular cloning of ID4, a novel dominant negative helix-loop-helix human gene on chromosome 6p21.3-p22 Genomics 27 1995 200 203
14. J.D. Norton, R.W. Deed, G. Craggs, and F. Sablitzky Id helix-loop-helix proteins in cell growth and differentiation Trends Cell Biol. 8 1998 58 65
15. A. Lasorella, A. Iavarone, and M.A. Israel Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins Mol. Cell Biol. 16 1996 2570 2578
16. A. Iavarone, P. Garg, A. Lasorella, J. Hsu, and M.A. Israel The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein Genes Dev. 8 1994 1270 1284
17. K.L. Guan, C.W. Jenkins, Y. Li, M.A. Nichols, X. Wu, C.L. O'Keefe, A.G. Matera, and Y. Xiong Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function Genes Dev. 8 1994 2939 2952
18. D. Tvrdik, R. Djaborkhel, A. Nagy, T. Eckschlager, I. Raska, and J. Muller Cyclin D-cdk6 complex is targeted by p21(WAF) in growth-arrested lymphoma cells J. Struct. Biol. 140 2002 49 56
19. J. Kopp, and T. Schwede The SWISS-MODEL repository of annotated three-dimensional protein structure homology models Nucleic Acids Res. 32 2004 D230 D234 Database issue
20. N.P. Pavletich Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors J. Mol. Biol. 287 1999 821 828
21. B.G. Novitch, G.J. Mulligan, T. Jacks, and A.B. Lassar Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle J. Cell Biol. 135 1996 441 456
22. E.J. Morris, and N.J. Dyson Retinoblastoma protein partners Adv. Cancer Res. 82 2001 1 54
23. J. Sambrook, and D.W. Russell Molecular Cloning 2001 CSHL Press Cold Spring Harbor
24. T. Weber, R. Baumgartner, C. Renner, M.A. Marahiel, and T.A. Holak Solution structure of PCP, a prototype for the peptidyl carrier domains of modular peptide synthetases Struct. Fold Des. 8 2000 407 418
25. T. Rehm, R. Huber, and T.A. Holak Application of NMR in structural proteomics: screening for proteins amenable to structural analysis Structure (Camb.) 10 2002 1613 1618
26. K. Wüthrich NMR of Proteins and Nucleic Acids 1986 Wiley New York
27. P.C. Ma, M.A. Rould, H. Weintraub, and C.O. Pabo Crystal structure of MyoD bHLH domain-DNA complex: perspectives on DNA recognition and implications for transcriptional activation Cell 77 1994 451 459
28. Q.J. Hu, N. Dyson, and E. Harlow The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations EMBO J. 9 1990 1147 1155
29. S. Huang, N.P. Wang, B.Y. Tseng, W.H. Lee, and E.H. Lee Two distinct and frequently mutated regions of retinoblastoma protein are required for binding to SV40 T antigen EMBO J. 9 1990 1815 1822
30. J.O. Lee, A.A. Russo, and N.P. Pavletich Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 Nature 391 1998 859 865
31. K.N. Chow, and D.C. Dean Domains A and B in the Rb pocket interact to form a transcriptional repressor motif Mol. Cell. Biol. 16 1996 4862 4868
32. W.G. Kaelin Jr., M.E. Ewen, and D.M. Livingston Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product Mol. Cell. Biol. 10 1990 3761 3769
33. B. Xiao, J. Spencer, A. Clements, N. Ali-Khan, S. Mittnacht, C. Broceno, M. Burghammer, A. Perrakis, R. Marmorstein, and S.J. Gamblin Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation Proc. Natl. Acad. Sci. U. S. A. 100 2003 2363 2368
34. Z.X. Xiao, J. Chen, A.J. Levine, N. Modjtahedi, J. Xing, W.R. Sellers, and D.M. Livingston Interaction between the retinoblastoma protein and the oncoprotein MDM2 Nature 375 1995 694 698
35. P.J. Welch, and J.Y. Wang A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle Cell 75 1993 779 790
36. D.C. Nguyen, and D.L. Crowe Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity Biochim. Biophys. Acta 1445 1999 207 215
37. R.D. Gietz, B. Triggs-Raine, A. Robbins, K.C. Graham, and R.A. Woods Identification of proteins that interact with a protein of interest: applications of the yeast two-hybrid system Mol. Cell. Biochem. 172 1997 67 79
38. G.G. Toby, and E.A. Golemis Using the yeast interaction trap and other two-hybrid-based approaches to study protein-protein interactions Methods 24 2001 201 217
39. T. Diercks, M. Coles, and H. Kessler Applications of NMR in drug discovery Curr. Opin. Chem. Biol. 5 2001 285 291
40. B. Meyer, and T. Peters NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors Angew. Chem., Int. Ed. Engl. 42 2003 864 890
41. M. Pellecchia, D.S. Sem, and K. Wuthrich NMR in drug discovery Nat. Rev., Drug Discov. 1 2002 211 219
42. R. Stoll, C. Renner, S. Hansen, S. Palme, C. Klein, A. Belling, W. Zeslawski, M. Kamionka, T. Rehm, P. Muhlhahn, R. Schumacher, F. Hesse, B. Kaluza, W. Voelter, R.A. Engh, and T.A. Holak Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53 Biochemistry 40 2001 336 344
43. C. Cenciarelli, F. De Santa, P.L. Puri, E. Mattei, L. Ricci, F. Bucci, A. Felsani, and M. Caruso Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation Mol. Cell. Biol. 19 1999 5203 5217
44. O. Halevy, B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD Science 267 1995 1018 1021
45. A. Magenta, C. Cenciarelli, F. De Santa, P. Fuschi, F. Martelli, M. Caruso, and A. Felsani MyoD stimulates RB promoter activity via the CREB/p300 nuclear transduction pathway Mol. Cell. Biol. 23 2003 2893 2906
46. A. Polesskaya, I. Naguibneva, A. Duquet, E. Bengal, P. Robin, and A. Harel-Bellan Interaction between acetylated MyoD and the bromodomain of CBP and/or p300 Mol. Cell. Biol. 21 2001 5312 5320
47. P.L. Puri, M.L. Avantaggiati, C. Balsano, N. Sang, A. Graessmann, A. Giordano, and M. Levrero p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription EMBO J. 16 1997 369 383
48. E.G. Reynaud, K. Pelpel, M. Guillier, M.P. Leibovitch, and S.A. Leibovitch p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts Mol. Cell. Biol. 19 1999 7621 7629
49. S.D. Zabludoff, M. Csete, R. Wagner, X. Yu, and B.J. Wold p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis Cell Growth Differ. 9 1998 1 11
50. A. Lasorella, M. Noseda, M. Beyna, Y. Yokota, and A. Iavarone Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins Nature 407 2000 592 598
51. S. Prabhu, A. Ignatova, S.T. Park, and X.H. Sun Regulation of the expression of cyclin-dependent kinase inhibitor p21 by E2A and Id proteins Mol. Cell. Biol. 17 1997 5888 5896
52. K. Helin, J.A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F Cell 70 1992 337 350
53. D.O. Morgan Cyclin-dependent kinases: engines, clocks, and microprocessors Annu. Rev. Cell Dev. Biol. 13 1997 261 291
54. A. Clements, K. Johnston, J.M. Mazzarelli, R.P. Ricciardi, and R. Marmorstein Oligomerization properties of the viral oncoproteins adenovirus E1A and human papillomavirus E7 and their complexes with the retinoblastoma protein Biochemistry 39 2000 16033 16045